Physician profile
Swaroop Bommareddi
NPI 1609142470
$25,656.98
in general payments reported to CMS, 2019-2025
12 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $102 · 2021: $1,484 · 2022: $1,463 · 2023: $22K · 2024: $362 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $17K · Travel and Lodging: $3,657 · Food and Beverage: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $16,800.00 |
| Travel and Lodging | $3,657.39 |
| Food and Beverage | $1,913.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $21,862.36 | 2022-2023 | Impella |
| Transmedics, INC. | $1,388.60 | 2021 | |
| Abbott Laboratories | $779.89 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Atricure, INC. | $460.51 | 2022-2024 | |
| Edwards Lifesciences Corporation | $237.34 | 2019 | |
| Balt USA, LLC | $188.19 | 2025 | Optima Coil System |
| Kci USA, INC. | $156.26 | 2023 | Prevena, Bair Hugger |
| Xvivo Perfusion INC. | $148.22 | 2023 | |
| Baxter Healthcare | $147.75 | 2023 | Coseal, Ostene, Seprafilm |
| Medtronic Vascular, INC. | $101.71 | 2020 | |
| Medtronic, INC. | $95.87 | 2021 | |
| Depuy Synthes Sales INC. | $90.28 | 2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swaroop Bommareddi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.